Su Zhen Insider Trades

Insider Trading History

Track insider trading activity for Su Zhen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $140k 15,508 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 15,508 shares
$8.06
$9.00
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $122k 38,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 38,000 shares
$2.82
$3.22
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $41.4k 4,600 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.6k 4,600 shares
$4.48
$9.00
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $455k 50,587 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$730k 50,587 shares
$14.43
$9.00
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $122k 38,000 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.5k 38,000 shares
$1.96
$3.22
CytomX Therapeutics
CytomX Therapeutics CTMX
Director
Holding Value $245k 76,000 shares
Last Trade
Mar 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 76,000 shares
$2.27
$3.22
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $612k 68,000 shares
Last Trade
Aug 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 68,000 shares
$19.20
$9.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up